Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-09-29

FDA Approved: AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for a generic fixed-dose combination tablet containing amlodipine, valsartan, and hydrochlorothiazide from Aurobindo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE (amlodipine/valsartan/hydrochlorothiazide)

Snippet

SUPPL AP for AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE (AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE)